AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$38.12
arrow_upward
+0.24%(+0.090) 1 天
US$38.35
arrow_upward
+0.60% (+0.23)today开盘前
休市： 10月28日, GMT-4 16:00:00 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 AGIO 生成关键数据洞见…
开盘价
US$37.46
最高价
US$38.44
最低价
US$36.86
市值
22.76亿
平均成交量
115.35万
成交量
1.00
52 周最高价
US$45.99
52 周最低价
US$22.24
每股收益
-US$7.01
Beta 版
0.63
流通股数
5970.20万
员工人数
540
开盘价
US$37.46
最高价
US$38.44
最低价
US$36.86
市值
22.76亿
平均成交量
115.35万
成交量
1.00
52 周最高价
US$45.99
52 周最低价
US$22.24
每股收益
-US$7.01
Beta 版
0.63
流通股数
5970.20万
员工人数
540
新闻报道
来自网络来源和新闻合作伙伴
www.marketscreener.com
·
14小时前
Agios Pharmaceuticals Insider Sold Shares Worth $296,470, According to a Recent SEC Filing
Investing.com Nigeria
·
2天前
Form 144 AGIOS PHARMACEUTICALS For: 27 October By Investing.com
资料
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Agios Pharmaceuticals Inc简介